The nation of Zimbabwe has declined a major American healthcare agreement worth 367 million US dollars (£272m) over five years because of the United States' insistence on sensitive biological samples.
This move was revealed after a government memo dated December was disclosed, revealing that Head of State Emmerson Mnangagwa felt the arrangement was "unbalanced".
An official spokesman has since explained that the US was demanding access to biological samples for research and profit while was unwilling to share the benefits from future vaccines.
"We are forced to start the difficult and regrettable task of winding down our support in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont in a statement.
Her embassy noted the US had furnished more than $1.9bn as health assistance to Zimbabwe during the past two decades.
A doctors' association in Zimbabwe has appealed for more talks to secure a agreement acceptable to both sides so the country's critical HIV programme can be sustained.
Broader Context
This development comes after a similar situation in neighbouring Kenya, where a high court blocked a related health funding agreement after legal challenges were raised about the security of citizens' medical information.
Since returning to office last year, US President Donald Trump has drastically cut foreign aid and shut down the US Agency for International Development (USAID).
USAID had overseen aid for the US government, but Trump stated its spending was "wasteful" and his administration was pursuing direct bilateral agreements to boost openness and accountability.
According to statements, 16 African countries have so far signed similar health pacts, constituting more than $18.3bn in committed funds.
Specifics of the Rejected Deal
The money for Zimbabwe would have supported "tackling HIV/Aids, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.
"We are confident this partnership would have delivered immense advantages for the people of Zimbabwe, particularly the 1.2 million presently on HIV treatment via American-funded programmes," Tremont commented.
However, government spokesperson Nick Mangwana said the arrangement was "asymmetrical".
"Zimbabwe was being asked to provide its genetic material and health information indefinitely, with no corresponding assurance of access to any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that could be developed from that provided information," Mangwana explained.
"Put simply, our nation would provide the raw materials for scientific discovery without any assurance that the resulting innovations would be accessible to our population should a new disease outbreak emerge."
National Interest and Global Health
He also said that the American exit from the World Health Organization (WHO) and its pursuit of bilateral deals were upending systems already set up via the global organization.
Mangwana gave as an example its Pandemic Benefit-Sharing framework designed to deal with potential global health emergencies.
"This system is intended to guarantee that when a nation provides its samples, the resulting advantages – including medicines and cures – are distributed fairly, not commercialised exclusively by those with the capability to develop them."
The government's concerns regarding the US deal "must not be interpreted as hostility towards the US," Mangwana stressed.
"We are open to continued dialogue with our American counterparts on how subsequent co-operation could be designed in a way that respects the independence and interests of both nations."
Medical Community Reaction
Medical experts expressed it recognised the government's concerns, but urged that talks should continue considering much of the nation's Aids initiatives relied on foreign aid.
"Where specific concerns arise, including those relating to data governance or agreement terms, these can often be addressed via technical clarification and mutually agreed protections," the group added.
This impasse highlights the complex debate between accepting vital international aid and safeguarding national sovereignty in an increasingly interconnected world.